Safety, Tolerability, and Immunogenicity of Plasmodium falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children
收藏DataCite Commons2022-12-21 更新2025-04-16 收录
下载链接：
https://www.immport.org/shared/study/SDY1711
下载链接
链接失效反馈官方服务：
资源简介：
KSPZV1 Part 2 is a single center, randomized, double-blind, placebo-controlled trial enrolling 336 malaria-exposed Kenyan children ages 5 to 12 months at the time of first vaccination. Subjects were randomized to 1 of 4 groups in a 1:1:1:1 ratio to receive 3 doses at 8-week intervals of either 4.5 x10^5, 9.0 x10^5, or 1.8 x10^6 PfSPZ or normal saline as a control.
提供机构：
ImmPort
创建时间：
2021-05-26
